当前位置:首页 - 行情中心 - 微芯生物(688321) - 财务分析 - 现金流量表

微芯生物

(688321)

  

流通市值:111.53亿  总市值:111.53亿
流通股本:4.43亿   总股本:4.43亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金563,582,862.26268,618,755.61837,530,470.82600,839,571.42
  收到其他与经营活动有关的现金2,011,791.661,434,238.1840,669,807.5436,992,053.51
  经营活动现金流入小计565,594,653.92270,052,993.79878,200,278.36637,831,624.93
  购买商品、接受劳务支付的现金35,237,666.3315,453,080.3467,762,633.2648,540,672.87
  支付给职工以及为职工支付的现金172,097,134.13102,931,064.51315,576,668.48246,368,451.96
  支付的各项税费39,094,456.9715,525,962.0347,429,193.8930,129,889.37
  支付其他与经营活动有关的现金229,800,322.95111,798,928.8350,466,424.44252,870,535.95
  经营活动现金流出小计476,229,580.38245,709,035.68781,234,920.07577,909,550.15
  经营活动产生的现金流量净额89,365,073.5424,343,958.1196,965,358.2959,922,074.78
二、投资活动产生的现金流量:
  收回投资收到的现金1,205,610,108.26305,681,247.631,648,646,830.261,101,320,011.15
  取得投资收益收到的现金7,824,040.394,463,131.5118,839,001.29,530,779.85
  处置固定资产、无形资产和其他长期资产收回的现金净额33,633.4516,363.9813,772.7813,772.78
  投资活动现金流入小计1,213,467,782.1310,160,743.121,667,499,604.241,110,864,563.78
  购建固定资产、无形资产和其他长期资产支付的现金170,994,824.24100,502,759.4178,602,604.92114,938,351.16
  投资支付的现金1,554,663,548.47903,854,849.591,706,512,516.661,144,869,696.66
  投资活动现金流出小计1,725,658,372.711,004,357,608.991,885,115,121.581,259,808,047.82
  投资活动产生的现金流量净额-512,190,590.61-694,196,865.87-217,615,517.34-148,943,484.04
三、筹资活动产生的现金流量:
  吸收投资收到的现金938,339,997.44938,339,997.44--
  取得借款收到的现金330,524,000110,524,000491,902,465401,885,265
  筹资活动现金流入小计1,268,863,997.441,048,863,997.44491,902,465401,885,265
  偿还债务支付的现金390,229,368.34123,961,536.67310,941,816.68208,970,280.01
  分配股利、利润或偿付利息支付的现金38,734,750.456,464,846.7131,742,274.0725,439,063.56
  支付其他与筹资活动有关的现金56,529,803.665,220,035.0421,618,223.953,502,845.31
  筹资活动现金流出小计485,493,922.45135,646,418.42364,302,314.7237,912,188.88
  筹资活动产生的现金流量净额783,370,074.99913,217,579.02127,600,150.3163,973,076.12
四、汇率变动对现金及现金等价物的影响-1,393,957.95-788,180.1-807,474.93-1,729,409.36
五、现金及现金等价物净增加额359,150,599.97242,576,491.166,142,516.3273,222,257.5
  加:期初现金及现金等价物余额228,682,925.18228,682,925.18222,540,408.86222,540,408.86
  期末现金及现金等价物余额587,833,525.15471,259,416.34228,682,925.18295,762,666.36
补充资料:
  净利润71,380,590.11-50,959,162.56-
  固定资产和投资性房地产折旧21,204,220.57-36,463,907.12-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧21,204,220.57-36,463,907.12-
  无形资产摊销15,802,119.84-31,287,590.47-
  长期待摊费用摊销1,346,667.11-2,840,932.43-
  处置固定资产、无形资产和其他长期资产的损失-6,650---
  固定资产报废损失80,769.77-69,711.8-
  公允价值变动损失-1,431,165.15--238,945.2-
  财务费用17,921,658.03-22,789,141.43-
  投资损失14,005,368.5-25,076,401.36-
  递延所得税1,307,845.59--1,454,462.3-
  其中:递延所得税资产减少266,095.04--1,368,285.04-
    递延所得税负债增加1,041,750.55--86,177.26-
  存货的减少-8,795,352.43--16,838,616.46-
  经营性应收项目的减少-15,398,421.23--160,139,574.06-
  经营性应付项目的增加-27,370,829.1-102,645,815.36-
  其他-2,548,208.44--1,969,373.64-
  现金的期末余额587,833,525.15-228,682,925.18-
  减:现金的期初余额228,682,925.18-222,540,408.86-
  现金及现金等价物的净增加额359,150,599.97-6,142,516.32-
公告日期2026-08-202026-04-302026-03-312025-10-31
审计意见(境内)标准无保留意见
TOP↑